Stability of cytoplasmic nanoviscosity during cell cycle of HeLa cells synchronized with Aphidicolin

Sci Rep. 2019 Nov 11;9(1):16486. doi: 10.1038/s41598-019-52758-6.

Abstract

Nanoviscosity of the cytoplasm is a key factor affecting diffusion of biomolecules and - as a consequence - rates of biochemical reactions in a cell. Nanoviscosity is an outcome of variable chemical and structural factors, which can temporarily change with cell-cycle associated changes of intracellular architecture. Thus, the question arises, whether rates of biochemical reactions depend on the point of cell cycle. In this paper we address this topic by constant observation of nanoviscosity of HeLa cells cytoplasm during S, G2 and G1 phases after Aphidicolin synchronization. For this purpose we measured diffusion rates of EGFP molecules using fluorescence correlation spectroscopy (FCS). To our surprise, a counter-intuitive stability of cytoplasmic viscosity was observed during the cell cycle. Our results hint at possible existence of robust mechanism maintaining stable physiological viscosity of the cytoplasm, despite huge structural changes during cell cycle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aphidicolin / pharmacology*
  • Biophysical Phenomena / drug effects*
  • Cell Cycle / drug effects*
  • Cell Size
  • Cytoplasm / drug effects*
  • Cytoplasm / metabolism
  • Flow Cytometry
  • HeLa Cells
  • Humans
  • Viscosity / drug effects

Substances

  • Aphidicolin